Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms

NCT04177576 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT04177576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04177576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
February 24, 2020
Completion date
January 26, 2022
Enrollment
397 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative neoplasm